BMY-25551 is a mitomycin (MMC) derivative. BMY-25551 has been shown to be 8 to 20 times more potent than mitomycin C (MMC) in cytotoxicity to murine and human tumor cell lines. BMY-25551 appears to be more effective in tumor inhibition than MMC against P388 leukemia and B16 melanoma in mice. BMY-25551 is comparable to MMC in hematologic depression in mice.
MedKoo Cat#: 145227
Name: BMY-25551
CAS#: 105139-98-8
Chemical Formula: C17H21N3O7
Exact Mass: 379.1380
Molecular Weight: 379.37
Elemental Analysis: C, 53.82; H, 5.58; N, 11.08; O, 29.52
The following data is based on the product molecular weight 379.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |